210 related articles for article (PubMed ID: 35317170)
1. Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review.
Xie YH; Wang SH; Li SZ; Zuo YG
Front Immunol; 2022; 13():839094. PubMed ID: 35317170
[TBL] [Abstract][Full Text] [Related]
2. Anti-p200 Pemphigoid: A Systematic Review.
Kridin K; Ahmed AR
Front Immunol; 2019; 10():2466. PubMed ID: 31695695
[TBL] [Abstract][Full Text] [Related]
3. Potential contribution of anti-p200 autoantibodies to mucosal lesions in anti-p200 pemphigoid.
Gao Y; Qian H; Hashimoto T; Li X
Front Immunol; 2023; 14():1118846. PubMed ID: 36761755
[TBL] [Abstract][Full Text] [Related]
4. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
5. Treatment and clinical outcomes in anti-p200 pemphigoid: a systematic review.
Laufer Britva R; Amber KT; Cohen AD; Kridin K
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):465-472. PubMed ID: 31536652
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological features and outcome of anti-p200 pemphigoid.
Commin MH; Schmidt E; Duvert-Lehembre S; Lasek A; Morice C; Estival JL; Debarbieux S; Rigal E; Pauwels C; De Quatrebarbes J; Roussel A; Goujon E; Stoebner PE; Jouen F; Joly P
Br J Dermatol; 2016 Oct; 175(4):776-81. PubMed ID: 27037896
[TBL] [Abstract][Full Text] [Related]
7. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
8. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
9. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
10. Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid.
Goletz S; Pigors M; Lari TR; Hammers CM; Wang Y; Emtenani S; Aumailley M; Holtsche MM; Stang FH; Weyers I; König IR; Has C; Radzimski C; Komorowski L; Zillikens D; Schmidt E
J Am Acad Dermatol; 2024 Apr; 90(4):790-797. PubMed ID: 37992812
[TBL] [Abstract][Full Text] [Related]
11. [Anti-p200 pemphigoid].
Holtsche MM; Goletz S; Zillikens D
Hautarzt; 2019 Apr; 70(4):271-276. PubMed ID: 30868255
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases.
Ohata C; Ishii N; Koga H; Fukuda S; Tateishi C; Tsuruta D; Furumura M; Hashimoto T
J Am Acad Dermatol; 2015 Jul; 73(1):50-5. PubMed ID: 25896671
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti-p200 pemphigoid.
Kitayama S; Makino T; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
J Dermatol; 2023 Sep; 50(9):1194-1198. PubMed ID: 37082790
[TBL] [Abstract][Full Text] [Related]
14. Pathogenicity of autoantibodies in anti-p200 pemphigoid.
Vafia K; Groth S; Beckmann T; Hirose M; Dworschak J; Recke A; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
PLoS One; 2012; 7(7):e41769. PubMed ID: 22911854
[TBL] [Abstract][Full Text] [Related]
15. [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].
Drerup KA; Wehkamp U
Hautarzt; 2020 Feb; 71(2):130-133. PubMed ID: 31501972
[TBL] [Abstract][Full Text] [Related]
16. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
[TBL] [Abstract][Full Text] [Related]
17. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
18. Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.
Yasuda H; Tomita Y; Shibaki A; Hashimoto T
Dermatology; 2004; 209(2):149-55. PubMed ID: 15316172
[TBL] [Abstract][Full Text] [Related]
19. A long-term study of a patient with anti-p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading.
Monshi B; Groth S; Richter L; Schmidt E; Zillikens D; Rappersberger K
Br J Dermatol; 2012 Nov; 167(5):1179-83. PubMed ID: 22639938
[TBL] [Abstract][Full Text] [Related]
20. Anti-laminin gamma-1 pemphigoid.
Dainichi T; Kurono S; Ohyama B; Ishii N; Sanzen N; Hayashi M; Shimono C; Taniguchi Y; Koga H; Karashima T; Yasumoto S; Zillikens D; Sekiguchi K; Hashimoto T
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2800-5. PubMed ID: 19196964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]